Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-cash Items (2022 - 2025)

Roivant Sciences (ROIV) has disclosed Non-cash Items for 4 consecutive years, with $113.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-cash Items rose 7.94% year-over-year to $113.0 million, compared with a TTM value of $113.0 million through Jun 2025, up 7.94%, and an annual FY2025 reading of $384.0 million, down 23.12% over the prior year.
  • Non-cash Items was $113.0 million for Q2 2025 at Roivant Sciences, down from $384.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $499.5 million in Q1 2024 and bottomed at $1.9 million in Q1 2022.
  • Average Non-cash Items over 4 years is $151.4 million, with a median of $104.7 million recorded in 2024.
  • The sharpest move saw Non-cash Items soared 14653.61% in 2023, then dropped 23.12% in 2025.
  • Year by year, Non-cash Items stood at $55.6 million in 2022, then surged by 64.78% to $91.7 million in 2023, then increased by 17.24% to $107.5 million in 2024, then grew by 5.16% to $113.0 million in 2025.
  • Business Quant data shows Non-cash Items for ROIV at $113.0 million in Q2 2025, $384.0 million in Q1 2025, and $107.5 million in Q4 2024.